Endocyte(ECYT)

成长中的操盘手2018-10-19 12:20

$Endocyte, Inc. (ECYT)$ 想看看收购能涨到去哪查看全文

淘沙见金2018-10-18 20:11

$Endocyte, Inc. (ECYT)$ 这个逆转牛啊，去年股价才一块多。Lu-PSMA-617 当时只花了12M就拿到了授权，现在公司靠这个卖出去$2.1B，这投资回报率也是无敌了。希望这只是MA的开始查看全文

【美股盘前】2020年或破万亿美元大关 巨额赤字成美经济增长隐忧

放眼观美股2018-10-18 18:57

一、要闻
1、2020年或破万亿美元大关 巨额赤字成美经济增长隐忧
美国财政部最新公布的数据显示，截至今年9月30日结束的2018财年，美国政府财政赤字较上年同期扩大17%至7790亿美元，创下2012年以来的最高水平。国会预算办公室预测，2019财年，美国政府财政赤字可能扩大至9730亿美元，2020...查看全文

Fran恪2018-09-18 00:30

$Affimed N.V. (AFMD)$ 我认为到4左右是买入机会，我的成本价也是4多一点，现在再考虑要不要再加仓。我认为未来一年半载AFMD很可能复制$Endocyte, Inc. (ECYT)$ 的走势，而且也许会更猛。AFMD最大的优势是罗氏的全力支持。当然和$Sorrento Therapeutics, Inc. (SRNE)$ 一样，能不能成功最后还是要...查看全文

PharmSeeker2018-08-14 11:13

$PGNX 1095 咋做得这么慢呢？一个临床一期要3年？太废柴了。看看 $Endocyte, Inc. (ECYT)$ 靠Lu-PSMA-617涨了10倍，今天仔细看看了结构式，target moiety都是一样的，人家都推到3期了查看全文

淘沙见金2018-07-03 01:46

$Endocyte, Inc. (ECYT)$ This stock has been sneaky strong when they have rebooted and instead of using chemo agents they are using radiation therapies. Their current drug 77Lu-PSMA-617 has had some really good data in prostate cancer and actually saw shrinkage in soft tissues...查看全文

Fran恪2018-06-13 00:24

$Endocyte, Inc. (ECYT)$ 去年关注过一阵子，想从5块掉下了后再买，后来竟然给忘记了这个公司，错失大好机会！查看全文

琳子的日复一日2018-05-17 23:44

$Endocyte, Inc. (ECYT)$ 在asco上展示的前列腺癌数据惊人啊，In 50 treated patients, 62% (n=31) experienced greater than a 50% reduction in PSA (prostate-specific antigen) levels while 44% (n=22) experienced at least an 80% reduction in PSA. Median overall survival was 13.5 mont...查看全文

BlockChain小爪2018-05-08 00:39

$Endocyte, Inc. (ECYT)$ NB啊，高位还能涨这么多，这股票只有一个方向啊，就是涨查看全文

PxpOnCa2018-04-14 00:48

$Endocyte, Inc. (ECYT)$ 9.85入了 大趋势给力查看全文

$Endocyte(ECYT)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-14 AccNo: 0001144204-19-008377 Size: 108 KB 网页链接

$Endocyte(ECYT)$ 15-12B - Securities registration termination [Section 12(b)] Filed: 2018-12-31 AccNo: 0001104659-18-075251 Size: 22 KB 网页链接

$Endocyte(ECYT)$ EFFECT - Notice of Effectiveness Filed: 2018-12-26 AccNo: 9999999995-18-003223 Size: 1 KB 网页链接

$Endocyte(ECYT)$ 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Filed: 2018-12-21 AccNo: 0001354457-18-000537 Size: 2 KB 网页链接

$Endocyte(ECYT)$ 8-K - Current report Filed: 2018-12-21 AccNo: 0001104659-18-074311 Size: 183 KBItem 2.01: Completion of Acquisition or Disposition of AssetsItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingItem 3.03...

$Endocyte(ECYT)$ POSASR - Post-effective Amendment to an automatic shelf registration statement Filed: 2018-12-21 AccNo: 0001104659-18-074312 Size: 27 KB 网页链接

$Endocyte(ECYT)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2018-12-21 AccNo: 0001104659-18-074314 Size: 53 KB 网页链接

$Endocyte(ECYT)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2018-12-21 AccNo: 0001104659-18-074315 Size: 53 KB 网页链接

$Endocyte(ECYT)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2018-12-21 AccNo: 0001104659-18-074316 Size: 53 KB 网页链接

$Endocyte(ECYT)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2018-12-21 AccNo: 0001104659-18-074317 Size: 53 KB 网页链接